Xepapadaki, Paraskevi
Megremis, Spyridon
Rovina, Nikoletta
Wardzyńska, Aleksandra
Pasioti, Maria
Kritikou, Maria
Papadopoulos, Nikolaos G.
,
Kaltsas, Grigoris
Lebessi, Evangelia
Doudoulakakis, Anastassios
Taka, Stella
Tzanopoulou, Panagiota Tzani
Legaki, Evangelia
Stergiou, Rena
Robertson, David
Gilman, Tucker
Muldoon, Mark
Tapinos, Avraam
Yap, Chuan Fu
Gkimpas, George
Busby, Joe
Akdis, Mubeccel
Akdis, Cezmi
Globinska, Anna
Rozumbetov, Ramazan
Andreakos, Vangelis
Galani, Ioanna
Koutrouli, Mikaela
Triantafullia, Vaso
Wanstall, Hannah
Papadaki, Maria
Kowalski, Marek†
Wardzyńska, Aleksandra
Chałubiński, Maciej
Chanishvili, Nina
Kakabadze, Elene
Goderdzishvili, Marina
Ramiconi, Valeria
Proano, Isabel
Romagosa, Sofia
Ilioudis, Christos
Thanopoulou, Athina
Raptis, Dimitris
Funding for this research was provided by:
HORIZON EUROPE Framework Programme (767015)
Article History
Received: 26 February 2024
Accepted: 2 May 2024
First Online: 30 May 2024
Declarations
:
: Paraskevi Xepapadaki reports outside the submitted work payment or honoraria for lectures, presentations, speakers’ bureaus, Galenica, GlaxoSmithKline, Menarini, Novartis, Uriach, Nestle, Nutricia. Nikoloas G. Papadopoulos reports grants or contracts from any entity Capricare, Nestle, Numil, Vianex, consulting fees from Abbott, AbbVie, Astra Zeneca, GSK, HAL, Medscape, Menarini/Faes Farma, Mylan, Novartis, Nutricia, OM Pharma, Regeneron/Sanofi, outside the submitted work. NGP is an Editorial Board member of Pulmonary Therapy. Nikos Papadopoulos was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Spyridon Megremis, Nikoletta Rovina, Aleksandra Wardzynska, Maria Pasioti, Maria Kritikou have nothing to declare.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.